Age-related Terminal Duct Lobular Unit Involution in Benign Tissues from Chinese Breast Cancer Patients with Luminal and Triple-Negative Tumors.

Changyuan Guo,Hyuna Sung,Shan Zheng,Jennifer Guida,Erni Li,Jing Li,Nan Hu,Joseph Deng,Jonine D. Figueroa,Mark E. Sherman,Gretchen L. Gierach,Ning Lu,Xiaohong R. Yang
DOI: https://doi.org/10.1186/s13058-017-0850-5
2017-01-01
Breast Cancer Research
Abstract:Terminal duct lobular unit (TDLU) involution is a physiological process of breast tissue aging characterized by a reduction in the epithelial component. In studies of women with benign breast disease, researchers have found that age-matched women with lower levels of TDLU involution are at increased risk of developing breast cancer. We previously showed that breast cancer cases with core basal phenotype (CBP; estrogen receptor negative [ER−], progesterone receptor-negative [PR−], human epidermal growth factor receptor 2-negative [HER2−], cytokeratins (CK 5 or CK5/6)-positive [CK5/6+] and/or epidermal growth factor receptor-positive [EGFR+]) tumors had significantly reduced TDLU involution compared with cases with luminal A (ER+ and/or PR+, HER2−, CK5/6−, EGFR−) tumors from a population-based case-control study in Poland. We evaluated the association of TDLU involution with tumor subtypes in an independent population of women in China, where the breast cancer incidence rate, prevalence of known risk factors, and mammographic breast density are thought to be markedly different from those of Polish women.
What problem does this paper attempt to address?